Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

Updated

Apr. 11, 2023

Reviewed

Apr. 11, 2023

Fixed-Dose Combinations

View full version of Appendix A, Table 1.

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

 

Fixed-Dose Combinations

View full version of Appendix A, Table 1.

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

 

Download Guidelines

• Section OnlyPDF (104.25 KB)
• Full GuidelinePDF (5.42 MB)
• Recommendations OnlyPDF (942.22 KB)
• Tables OnlyPDF (1.43 MB)
• Drug Tables OnlyPDF (2.57 MB)

Related Content

• Clinicalinfo Drug Database
• HIVinfo Fact Sheets: HIV and Children and Adolescents
• HIVinfo Infographics
• AETC National HIV Curriculum
• How to Cite These Guidelines
• Pediatric ARV Archived Guidelines